NYSE:VEEV (USA) Also trade in: Germany Mexico

Veeva Systems Inc

$ 137.11 0.46 (0.34%)
Volume: 694,529 Avg Vol (1m): 1,294,757
Market Cap $: 20.08 Bil Enterprise Value $: 18.99 Bil
P/E (TTM): 93.28 P/B: 16.10
Earnings Power Value 14.87
Net Current Asset Value 7
Tangible Book 7.69
Projected FCF 18.84
Median P/S Value 73.81
Graham Number 15.95
Peter Lynch Value 36.75
DCF (FCF Based) 0
DCF (Earnings Based) 0
YTD (-%)

Financial Strength : 10/10

Current vs industry vs history
Cash-to-Debt No Debt
N/A
Equity-to-Asset 0.75
Interest Coverage No Debt
N/A
Piotroski F-Score 7
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 29.27
DISTRESS
GREY
SAFE
Beneish M-Score -2.48
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 244.13%
WACC 12.53%

Profitability & Growth : 9/10

Current vs industry vs history
Operating Margin % 25.85
Net Margin % 26.66
ROE % 21.80
ROA % 16.58
ROC (Joel Greenblatt) % 423.59
3-Year Total Revenue Growth Rate 28.20
3-Year Total EBITDA Growth Rate 39.60
3-Year EPS w/o NRI Growth Rate 57.00

» VEEV's 30-Y Financials

Financials (Next Earnings Date: 2019-05-24)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:VEEV

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Application Software » Health Information Services    NAICS : 511210    SIC : 8099
Compare NAS:ATHN NAS:HQY NAS:MDSO XTER:COP NYSE:TDOC SZSE:300253 NAS:CERN NAS:PINC NAS:OMCL NAS:INOV HKSE:02666 NYSE:EVH SZSE:300451 NAS:QSII NAS:TRHC NAS:HSTM NAS:RCM TSE:3902 LSE:CRW LSE:EMIS
Traded in other countries VEE.Germany
Address 4280 Hacienda Drive, Pleasanton, CA, USA, 94588
Veeva Systems largely provides cloud-based software to customers in the life sciences industry for customer relationship, content, and data management. Veeva CRM is a suite of applications that help pharmaceutical and biotechnology companies market and sell products to healthcare providers. Veeva Vault, a product built on proprietary software, is a cloud-based application built to manage content and associated data.

Ratios

Current vs industry vs history
PE Ratio (TTM) 93.28
Forward PE Ratio 71.94
N/A
PE Ratio without NRI 93.28
Price-to-Owner-Earnings 104.92
PB Ratio 16.10
PS Ratio 24.78
Price-to-Free-Cash-Flow 70.79
Price-to-Operating-Cash-Flow 68.58
EV-to-EBIT 85.14
EV-to-EBITDA 80.15
EV-to-Revenue 22.00
PEG Ratio 3.88
Current Ratio 3.57
Quick Ratio 3.57
Days Sales Outstanding 128.47
Days Payable 13.56

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -2.90

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 17.83
Price-to-Projected-FCF 7.28
Price-to-Median-PS-Value 1.86
Price-to-Peter-Lynch-Fair-Value 3.73
Price-to-Graham-Number 8.60
Earnings Yield (Joel Greenblatt) % 1.22
Forward Rate of Return (Yacktman) % 20.77

More Statistics

Revenue (TTM) (Mil) $ 862.21
EPS (TTM) $ 1.47
Beta 1.66
Volatility % 48.65
52-Week Range $ 68.11 - 138.05
Shares Outstanding (Mil) 146.43

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 7
Positive ROA Y
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N